当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析

尔康制药

(300267)

  

流通市值:45.66亿  总市值:66.21亿
流通股本:14.22亿   总股本:20.63亿

尔康制药(300267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.24亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益441475.91万元,未分配利润119420.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产512432.97万元,负债70957.06万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入353,547,866.171,139,612,276.29854,289,240.97621,346,708.93
营业总成本338,072,474.371,213,768,146.03893,553,175.63626,817,368.29
营业利润26,228,298.64-370,608,077.22-20,299,504.0211,734,714.77
利润总额26,586,884.54-388,117,806.27-23,697,483.588,634,864.55
净利润23,942,043.19-392,626,872.67-26,889,704.76,338,336.65
其他综合收益-11,550,621.21-15,464,320.82-85,012,752.5-38,766,130.01
综合收益总额12,391,421.98-408,091,193.49-111,902,457.2-32,427,793.36
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,676,715,416.551,717,081,656.361,679,049,957.441,692,247,929.11
非流动资产合计3,447,614,260.363,482,652,834.833,715,043,022.423,735,765,705.58
资产总计5,124,329,676.915,199,734,491.195,394,092,979.865,428,013,634.69
流动负债合计618,820,138.93705,342,064.26626,942,140.73585,831,343.41
非流动负债合计90,750,430.5192,198,616.4468,801,548.9364,362,766.16
负债合计709,570,569.44797,540,680.7695,743,689.66650,194,109.57
归属于母公司股东权益合计4,464,244,106.54,447,425,532.364,725,838,323.34,803,778,905.96
股东权益合计4,414,759,107.474,402,193,810.494,698,349,290.24,777,819,525.12
负债和股东权益合计5,124,329,676.915,199,734,491.195,394,092,979.865,428,013,634.69
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计344,190,570.111,252,255,073.92952,090,602.49677,520,811.61
经营活动现金流出小计348,339,077.011,085,563,367876,276,362.27549,891,834.96
经营活动产生的现金流量净额-4,148,506.9166,691,706.9275,814,240.22127,628,976.65
投资活动现金流入小计103,008,332.8212,514,361.74213,219,361.74152,090,828.86
投资活动现金流出小计29,637,797.69534,669,337.8474,507,107.01349,428,607.38
投资活动产生的现金流量净额73,370,535.11-322,154,976.06-261,287,745.27-197,337,778.52
筹资活动现金流入小计170,000,000796,080,000507,700,000457,700,000
筹资活动现金流出小计230,554,397.7654,935,595.34369,526,492.94316,345,286.98
筹资活动产生的现金流量净额-60,554,397.7141,144,404.66138,173,507.06141,354,713.02
汇率变动对现金及现金等价物的影响-1,106,513.25-6,409,837.1-9,550,453.85-7,918,486.54
现金及现金等价物净增加额7,561,117.26-20,728,701.58-56,850,451.8463,727,424.61
期末现金及现金等价物余额497,470,142.04489,909,024.78453,787,274.52574,365,150.97
TOP↑